ý

Filters close
Newswise: 1920_leo-mascarenhas-md-ms-cedars-sinai.jpg?10000
Released: 29-Apr-2024 7:05 PM EDT
Cedars-Sinai Guerin Children’s Expert Reelected to Leadership Position of Pediatric Oncology Organization
Cedars-Sinai

Cedars-Sinai Guerin Children’s pediatric oncologist Leo Mascarenhas, MD, MS, has been reelected as Children’s Oncology Group (COG) voting body chair for a second five-year term.

Released: 29-Apr-2024 6:05 PM EDT
Early Alzheimer’s Detection with Artificial Intelligence
Alzheimer's Center at Temple University Lewis Katz School of Medicine

“AI-driven neuroimaging techniques have the potential to improve prediction models for Alzheimer’s progression and facilitate personalized treatment strategies,” says Domenico Praticò, MD, the Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple (ACT), at the Lewis Katz School of Medicine at Temple University (LKSOM).

Released: 29-Apr-2024 5:10 PM EDT
AANA Presents U.S. Representative Jen Kiggans With National Health Leadership Award
American Association of Nurse Anesthesiology

The American Association of Nurse Anesthesiology (AANA) recognized U.S. Representative Jen Kiggans (R-VA) as the winner of its National Health Leadership Award for 2024 at its Mid-Year Assembly, April 20-24, in Washington, DC.

Released: 29-Apr-2024 5:00 PM EDT
AANA Presents U.S. Representative Elissa Slotkin With National Health Leadership Award
American Association of Nurse Anesthesiology

The American Association of Nurse Anesthesiology (AANA) recognized U.S. Representative Elissa Slotkin (D-MI) as the winner of its National Health Leadership Award for 2024 at its Mid-Year Assembly, April 20-24, in Washington, DC.

Not for public release

This news release is embargoed until 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 29-Apr-2024 4:30 PM EDT
The Association for Diagnostics & Laboratory Medicine (formerly AACC) opposes FDA ruling on laboratory developed tests; urges FDA to involve all stakeholders in modernization of laboratory developed test regulation in order to improve patient care
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

We at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) strongly disagree with the Food and Drug Administration’s (FDA’s) decision to issue a final rule placing laboratory developed tests under duplicative FDA authority, in addition to these tests’ current regulation under the Centers for Medicare & Medicaid Services (CMS).

Newswise: Vineyard Cares Business of the Year Presented to Huntsman Cancer Institute
Released: 29-Apr-2024 4:05 PM EDT
Vineyard Cares Business of the Year Presented to Huntsman Cancer Institute
Huntsman Cancer Institute at the University of Utah

The Vineyard Cares Business of the Year Award celebrates Huntsman Cancer Institute’s plan to establish a comprehensive cancer center in Vineyard, which will bring crucial cancer research and care closer to more communities in the region.

Newswise: Firefighter, a cancer survivor, discovers and embraces Sylvester’s large community of research and support
Released: 29-Apr-2024 4:05 PM EDT
Firefighter, a cancer survivor, discovers and embraces Sylvester’s large community of research and support
Sylvester Comprehensive Cancer Center

Naples (FL) firefighter, David Perez, initially kept his cancer diagnosis quiet, but now speaks out about the importance of fire fighter health and cancer in the fire service. “My eyes really opened up as to how many firefighters have been diagnosed with cancer and how many people there [Sylvester’s Firefighter Cancer Initiative] are fighting for us,” Perez said.

Released: 29-Apr-2024 4:05 PM EDT
نصائح خبراء مايو كلينك لحماية رئتيك وسط أدخنة حرائق الغابات
Mayo Clinic

عند اندلاع حرائق الغابات يواجه سكان المنطقة وفي بعض الأحيان المناطق خارجها، صعوبة متزايدة في التنفس. حيث تحمل الرياح الدخان لمسافة العديد من مئات الأميال من موقع الحريق الفعلي وفقًا لتصريح الطبيب كلايتون كاول، دكتور في الطب والذي يعمل كطبيب أمراض الرئة وعلم السموم الإكلينيكي في مايو كلينك.

Released: 29-Apr-2024 4:05 PM EDT
UCLA Health awarded up to $12.3 million as part of a federally funded moonshot effort to develop new treatments for osteoarthritis
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health is part of a multi-institution research team to receive a contract for up to $33 million from the federal Advanced Research Projects Agency for Health (ARPA-H) for the development of new treatments specifically focused on joint regeneration for osteoarthritis.

Released: 29-Apr-2024 3:05 PM EDT
Conselhos dos especialistas da Mayo Clinic sobre como proteger seus pulmões em meio à fumaça de incêndios florestais
Mayo Clinic

Quando os incêndios florestais se espalham, respirar para os habitantes da região e, às vezes, para além dela, pode se tornar cada vez mais difícil.

Released: 29-Apr-2024 3:05 PM EDT
Consejos de expertos de Mayo Clinic sobre cómo proteger sus pulmones en medio del humo de los incendios forestales
Mayo Clinic

A medida que los incendios forestales se propagan, respirar para los habitantes de la región y, a veces, más allá, puede volverse cada vez más difícil.

Newswise: Xavier Ochsner College of Medicine Announces Founding Dean and Location in Downtown New Orleans at Benson Tower
Released: 29-Apr-2024 3:05 PM EDT
Xavier Ochsner College of Medicine Announces Founding Dean and Location in Downtown New Orleans at Benson Tower
Ochsner Health

Xavier University of Louisiana (Xavier), a leading undergraduate institution in preparing Black students to successfully complete medical school, has announced continued progress with Ochsner Health (Ochsner), the Gulf South’s leading academic medical center in training physicians, to launch their transformational Xavier Ochsner College of Medicine (XOCOM).

Released: 29-Apr-2024 1:05 PM EDT
Study Finds School Entry Requirements Linked to Increased HPV Vaccination Rates
Wake Forest University School of Medicine

A new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.

access_time Embargo lifts in 2 days
This news release is embargoed until 1-May-2024 11:00 AM EDT Released to reporters: 29-Apr-2024 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-May-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Hongbo Chi, PhD named 2023 AAAS Fellow
Released: 29-Apr-2024 1:05 PM EDT
Hongbo Chi, PhD named 2023 AAAS Fellow
St. Jude Children's Research Hospital

Hongbo Chi, PhD, a faculty member and the Robert G. Webster Endowed Chair in Immunology at St. Jude Children’s Research Hospital, has been recognized as a fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science Family of Journals.

Newswise: Combler le fossé du traitement de l'épilepsie en Bolivie : trois décennies d'initiatives
Released: 29-Apr-2024 12:05 PM EDT
Combler le fossé du traitement de l'épilepsie en Bolivie : trois décennies d'initiatives
International League Against Epilepsy

Le déficit de traitement de l'épilepsie en Amérique latine est d'environ 60 %, mais le déficit de traitement dans les zones rurales de la région peut atteindre 90 %. En Bolivie, les facteurs contribuant à l'écart de traitement sont similaires aux facteurs dans d'autres régions éloignées à faibles ressources.

Released: 29-Apr-2024 12:05 PM EDT
TCT 2024 Career Achievement Award to be Presented to Robert A. Harrington, MD
Cardiovascular Research Foundation (CRF)

The TCT 2024 Career Achievement Award will be presented to Robert A. Harrington, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 27-30 2024, in Washington, DC at the Walter E. Washington Convention Center.

Newswise: Saint Louis University Researchers Identify a Biomarker for Severe Liver Disease in Infants
Released: 29-Apr-2024 12:05 PM EDT
Saint Louis University Researchers Identify a Biomarker for Severe Liver Disease in Infants
Saint Louis University

In a new study, Saint Louis University School of Medicine researchers and colleagues have identified biomarkers in high-risk infants with alpha-1 antitrypsin deficiency (AATD). This is a condition that is life-threatening in some infants but very mild in others. For the first time, predicting which children need lifesaving intervention is possible.

Newswise: Iowa State researchers identify genes linked to rice resiliency
Released: 29-Apr-2024 11:05 AM EDT
Iowa State researchers identify genes linked to rice resiliency
Iowa State University

Researchers at Iowa State University have identified two genes that can help rice defend itself against diseases, including the devastating fungal blast pathogen that regularly causes significant losses of rice production worldwide.

Released: 29-Apr-2024 11:05 AM EDT
Major League Baseball, U.S. Military Team Up for Performance Enhancing Substances Summit
Uniformed Services University of the Health Sciences (USU)

The Uniformed Services University’s (USU) Consortium for Health and Military Performance and its Operation Supplement Safety (OPSS) program is teaming up with Major League Baseball (MLB) to host the inaugural Performance Enhancing Substances (PES) Summit on May 1 at MLB headquarters in New York City.

Newswise: Cancer screening rates are significantly lower in US Federally Qualified Health Centers
Released: 29-Apr-2024 11:05 AM EDT
Cancer screening rates are significantly lower in US Federally Qualified Health Centers
University of New Mexico Comprehensive Cancer Center

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the US, relative to overall screening rates in the country.

Newswise: 1920_heartbeat-cedars-sinai.jpg?10000
Released: 29-Apr-2024 11:05 AM EDT
New Year, New Heart, New Lease on Life
Cedars-Sinai

Charles Schulz and his wife, Flor, sat in their living room on New Year’s Eve 2023, watching TV and counting down the seconds until the ball dropped in New York’s Times Square.

Newswise: Hackensack Meridian Jersey Shore University Medical Center Joins JFK University Medical Center and Hackensack University Medical Center in Providing Patients Advanced Lung Disease Diagnostic Technology
Released: 29-Apr-2024 11:05 AM EDT
Hackensack Meridian Jersey Shore University Medical Center Joins JFK University Medical Center and Hackensack University Medical Center in Providing Patients Advanced Lung Disease Diagnostic Technology
Hackensack Meridian Health

Experts at Hackensack Meridian Jersey Shore University Medical Center are now providing patients with minimally invasive, robotic-assisted bronchoscopy procedures with the Ion endoluminal system.

26-Apr-2024 9:05 AM EDT
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
Lombardi Comprehensive Cancer Center at Georgetown University

A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center.

Newswise: Cancer cell–immune cell interactions predict immunotherapy response
Released: 29-Apr-2024 10:05 AM EDT
Cancer cell–immune cell interactions predict immunotherapy response
UT Southwestern Medical Center

By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with breast cancer will respond to immunotherapies.

Newswise: Wayne State researcher receives grant from the National Multiple Sclerosis Society to explore new causes of MS
Released: 29-Apr-2024 10:05 AM EDT
Wayne State researcher receives grant from the National Multiple Sclerosis Society to explore new causes of MS
Wayne State University Division of Research

Alexander Gow, Ph.D., professor and associate director of the Center for Molecular Medicine and Genetics and professor of pediatrics and neurology at the Wayne State University School of Medicine, received an award from the National Multiple Sclerosis Society for a study into the causes of multiple sclerosis. The grant will explore the early roots of Multiple Sclerosis (MS) in patients that Gow believes may begin years — perhaps even decades — before symptoms become apparent.

Newswise: Experimental Type 1 Diabetes Drug Shelters Pancreas Cells From Immune System Attack
Released: 29-Apr-2024 10:00 AM EDT
Experimental Type 1 Diabetes Drug Shelters Pancreas Cells From Immune System Attack
Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine say that an experimental monoclonal antibody drug called mAb43 appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and in some cases, to lengthen the animals’ lifespan.

Newswise: Hackensack Meridian Health Appoints Emre Kayaalp, M.D., Ph.D, FACOG as Central Region Chair of Obstetrics & Gynecology
Released: 29-Apr-2024 9:05 AM EDT
Hackensack Meridian Health Appoints Emre Kayaalp, M.D., Ph.D, FACOG as Central Region Chair of Obstetrics & Gynecology
Hackensack Meridian Health

“Hackensack Meridian Health is a regional leader in high quality Obstetrics & Gynecology procedures,” said Todd Way, president, central region, Hackensack Meridian Health. “I’m thrilled to welcome Dr. Kayaalp. His expertise, leadership skills, and commitment to patient care will be invaluable to our organization.”

Newswise: Innovative Approach: KITECH Suggests Microplastic-Free Transparent Mask
Released: 29-Apr-2024 9:00 AM EDT
Innovative Approach: KITECH Suggests Microplastic-Free Transparent Mask
National Research Council of Science and Technology

The Korea Institute of Industrial Technology (KITECH) has introduced a new solution in the form of : a transparent mask, addressing concerns surrounding microplastic pollution and harmful solvents of conventional fibrous masks.

   
Newswise:Video Embedded icahn-school-of-medicine-at-mount-sinai-names-miriam-merad-md-phd-as-dean-for-translational-research-and-therapeutic-innovation
VIDEO
29-Apr-2024 9:00 AM EDT
Icahn School of Medicine at Mount Sinai Names Miriam Merad, MD, PhD, as Dean for Translational Research and Therapeutic Innovation
Mount Sinai Health System

Miriam Merad, MD, PhD, a world-renowned immunologist, has been appointed Dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. The appointment reaffirms Icahn Mount Sinai’s commitment to pioneering medical progress and catalyzing the rapid advancement of research innovation. Dr. Merad, the Mount Sinai Professor in Cancer Immunology, will also continue to serve as the founding Chair of the Department of Immunology and Immunotherapy, Director of the Marc and Jennifer Lipschultz Precision Immunology Institute, and Director of the Human Immune Monitoring Center. As Dean, Dr. Merad aims to elevate early clinical trials at Icahn Mount Sinai, streamline the clinical trial process, cultivate a culture of mechanistic clinical trials throughout the campus, and forge stronger partnerships with the pharmaceutical and biotech sectors.

Released: 29-Apr-2024 8:05 AM EDT
The Real Facts about Regener-Eyes®: A Commitment to Safety and Compliance
Regener-Eyes

Regener-Eyes® LLC, a leading name in the ophthalmic industry, is registered, regulated, inspected and in full compliance with all FDA regulations. Regener-Eyes® is dedicated to safety, quality, and compliance.

   
Newswise: #SexEdforAll Month (May) Shines Spotlight 
on Importance of Youth Sex Education
Released: 29-Apr-2024 8:05 AM EDT
#SexEdforAll Month (May) Shines Spotlight on Importance of Youth Sex Education
Candor Health Education

Recent data shows that kids are interested in and participating in sexual behavior. According to the CDC’s 2023 “Youth Risk Behavior Survey,” 30% of high school students reported being sexually active.

Newswise:Video Embedded ai-algorithms-can-determine-how-well-newborns-nurse-study-shows
VIDEO
Released: 29-Apr-2024 8:00 AM EDT
AI Algorithms Can Determine How Well Newborns Nurse, Study Shows
University of California San Diego

A modified pacifier and AI algorithms to analyze the data it produces could determine if newborns are learning the proper mechanics of nursing, a recent study shows. Specifically, the researchers from the University of California San Diego measured if babies are generating enough suckling strength to breastfeed and whether they are suckling in a regular pattern based on eight independent parameters.

Released: 29-Apr-2024 7:30 AM EDT
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Michigan Medicine - University of Michigan

By transplanting human neural stem cells, researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment, a study shows. Researchers say the improvements reported after stem cell transplantation must be further studied in mice before advancing to larger animals and, eventually, humans. 

access_time Embargo lifts in 2 days
This news release is embargoed until 1-May-2024 5:00 AM EDT Released to reporters: 29-Apr-2024 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-May-2024 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: After 25 Years, Researchers Uncover Genetic Cause of Rare Neurological Disease
25-Apr-2024 5:00 AM EDT
After 25 Years, Researchers Uncover Genetic Cause of Rare Neurological Disease
University of Utah Health

Spinocerebellar ataxia 4 is a devastating progressive movement disorder. A multinational study has now conclusively identified the genetic difference that causes the disease, bringing answers to families and opening the door to future treatments.

Newswise: Cardio-fitness cuts death and disease by nearly 20%
Released: 28-Apr-2024 11:05 PM EDT
Cardio-fitness cuts death and disease by nearly 20%
University of South Australia

Running, cycling, or swimming – if you regularly exercise, you’re well on track for a long and healthy life, as groundbreaking new research from the University of South Australia finds that an increased cardio fitness level will reduce your risk of death from any cause by 11-17%.

Newswise:Video Embedded welcome-to-a-world-where-we-can-cure-blindness-chronic-pain-and-neurological-diseases-with-3d-printed-surgical-implants
VIDEO
Released: 28-Apr-2024 7:05 PM EDT
Welcome to a world where we can cure blindness, chronic pain and neurological diseases with 3D printed surgical implants
University of South Australia

Clever bio-inks that sit inside the human body and restore damaged neurons could cure a whole swathe of diseases in the next 20 years: conditions that have baffled scientists and clinicians for centuries.

Newswise: Scientists suggested a new method for diagnosising of heart diseases
Released: 27-Apr-2024 3:05 PM EDT
Scientists suggested a new method for diagnosising of heart diseases
Scientific Project Lomonosov

Scientists from Immanuel Kant Baltic Federal University proved that Raman spectroscopy, a method by which diffusion property of substances is analyzed, can be used in diagnosing of coronary vascular diseases.

Newswise: Scientists have mathematically simulated an epileptic seizure for the first time
Released: 27-Apr-2024 3:05 AM EDT
Scientists have mathematically simulated an epileptic seizure for the first time
Scientific Project Lomonosov

Scientists at Immanuel Kant BFU have developed a mathematical model that describes human brain condition in epilepsy. The system reproduced changes in brain activity during a seizure, as well as taking into account multiple interactions among neurons and other brain cells.

   
Newswise: Three Johns Hopkins Medicine Researchers Named Fellows of the American Association for the Advancement of Science
Released: 26-Apr-2024 10:00 PM EDT
Three Johns Hopkins Medicine Researchers Named Fellows of the American Association for the Advancement of Science
Johns Hopkins Medicine

Three researchers from the Johns Hopkins University School of Medicine have been elected to the American Association for the Advancement of Science’s (AAAS) class of 2023 fellows.

26-Apr-2024 3:00 PM EDT
Glaucoma Research Foundation establishes Strategic Advisory Council
Glaucoma Research Foundation

The prestigious group brings together key industry leaders and members of the corporate community dedicated to glaucoma patient care.



close
1.59582